These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 23677314)
1. Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention. Peterson PN; Varosy PD; Heidenreich PA; Wang Y; Dewland TA; Curtis JP; Go AS; Greenlee RT; Magid DJ; Normand SL; Masoudi FA JAMA; 2013 May; 309(19):2025-34. PubMed ID: 23677314 [TBL] [Abstract][Full Text] [Related]
2. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators. Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811 [TBL] [Abstract][Full Text] [Related]
3. Gender and outcomes after primary prevention implantable cardioverter-defibrillator implantation: Findings from the National Cardiovascular Data Registry (NCDR). Russo AM; Daugherty SL; Masoudi FA; Wang Y; Curtis J; Lampert R Am Heart J; 2015 Aug; 170(2):330-8. PubMed ID: 26299231 [TBL] [Abstract][Full Text] [Related]
4. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention. Khazanie P; Hellkamp AS; Fonarow GC; Bhatt DL; Masoudi FA; Anstrom KJ; Heidenreich PA; Yancy CW; Curtis LH; Hernandez AF; Peterson ED; Al-Khatib SM J Am Heart Assoc; 2015 Aug; 4(8):e002061. PubMed ID: 26251283 [TBL] [Abstract][Full Text] [Related]
5. Use and Outcomes of Dual Chamber or Cardiac Resynchronization Therapy Defibrillators Among Older Patients Requiring Ventricular Pacing in the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry. Borne RT; Masoudi FA; Curtis JP; Zipse MM; Sandhu A; Hsu JC; Peterson PN JAMA Netw Open; 2021 Jan; 4(1):e2035470. PubMed ID: 33496796 [TBL] [Abstract][Full Text] [Related]
6. Longitudinal Outcomes Associated With Non-Evidence-Based Implantable Cardioverter-Defibrillators Among Medicare Beneficiaries (From the National Cardiovascular Data Registry). Daimee UA; Aslam F; Parzynski CS; Desai NR; Curtis JP Am J Cardiol; 2021 Sep; 155():64-71. PubMed ID: 34315569 [TBL] [Abstract][Full Text] [Related]
7. Real world effectiveness of primary implantable cardioverter defibrillators implanted during hospital admissions for exacerbation of heart failure or other acute co-morbidities: cohort study of older patients with heart failure. Chen CY; Stevenson LW; Stewart GC; Bhatt DL; Desai M; Seeger JD; Williams L; Jalbert JJ; Setoguchi S BMJ; 2015 Jul; 351():h3529. PubMed ID: 26174233 [TBL] [Abstract][Full Text] [Related]
8. Temporal trends in patient characteristics and outcomes among Medicare beneficiaries undergoing primary prevention implantable cardioverter-defibrillator placement in the United States, 2006-2010. Results from the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry. Borne RT; Peterson PN; Greenlee R; Heidenreich PA; Wang Y; Curtis JP; Tzou WS; Varosy PD; Kremers MS; Masoudi FA Circulation; 2014 Sep; 130(10):845-53. PubMed ID: 25095884 [TBL] [Abstract][Full Text] [Related]
9. Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study. Pun PH; Hellkamp AS; Sanders GD; Middleton JP; Hammill SC; Al-Khalidi HR; Curtis LH; Fonarow GC; Al-Khatib SM Nephrol Dial Transplant; 2015 May; 30(5):829-35. PubMed ID: 25404241 [TBL] [Abstract][Full Text] [Related]
10. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry. Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF; Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396 [TBL] [Abstract][Full Text] [Related]
11. Variation in use of dual-chamber implantable cardioverter-defibrillators: results from the national cardiovascular data registry. Matlock DD; Peterson PN; Wang Y; Curtis JP; Reynolds MR; Varosy PD; Masoudi FA Arch Intern Med; 2012 Apr; 172(8):634-41; discussion 641. PubMed ID: 22529229 [TBL] [Abstract][Full Text] [Related]
12. Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials. Al-Khatib SM; Hellkamp A; Bardy GH; Hammill S; Hall WJ; Mark DB; Anstrom KJ; Curtis J; Al-Khalidi H; Curtis LH; Heidenreich P; Peterson ED; Sanders G; Clapp-Channing N; Lee KL; Moss AJ JAMA; 2013 Jan; 309(1):55-62. PubMed ID: 23280225 [TBL] [Abstract][Full Text] [Related]
13. Single chamber implantable cardioverter defibrillator compared to dual chamber implantable cardioverter defibrillator: less is more! Data from the German Device Registry. Bogossian H; Frommeyer G; Hochadel M; Ince H; Spitzer SG; Eckardt L; Maier SKG; Kleemann T; Brachmann J; Stellbrink C; Gonska BD; Kääb S; Senges J; Lemke B Clin Res Cardiol; 2020 Jul; 109(7):911-917. PubMed ID: 31823040 [TBL] [Abstract][Full Text] [Related]
14. Single- Versus Dual-Chamber Implantable Cardioverter-Defibrillator for Primary Prevention of Sudden Cardiac Death in the United States. Margolis G; Hamuda N; Kobo O; Elbaz Greener G; Amir O; Homoud M; Madias C; Heist EK; Ruskin JN; Kazatsker M; Roguin A; Leshem E; Rozen G J Am Heart Assoc; 2023 Aug; 12(15):e029126. PubMed ID: 37522389 [TBL] [Abstract][Full Text] [Related]
15. Long-term Outcomes Associated With Implantable Cardioverter Defibrillator in Adults With Chronic Kidney Disease. Bansal N; Szpiro A; Reynolds K; Smith DH; Magid DJ; Gurwitz JH; Masoudi F; Greenlee RT; Tabada GH; Sung SH; Dighe A; Go AS JAMA Intern Med; 2018 Mar; 178(3):390-398. PubMed ID: 29404570 [TBL] [Abstract][Full Text] [Related]
16. Single-brand dual-chamber discriminators to prevent inappropriate shocks in patients implanted with prophylactic implantable cardioverter defibrillators: a propensity-weighted comparison of single- and dual-chamber devices. Briongos-Figuero S; Sánchez A; Pérez ML; Martínez-Ferrer JB; García E; Viñolas X; Arenal Á; Alzueta J; Basterra N; Rodríguez A; Lozano I; Muñoz-Aguilera R J Interv Card Electrophysiol; 2019 Apr; 54(3):267-275. PubMed ID: 30523511 [TBL] [Abstract][Full Text] [Related]